Life sciences are radically improving the chances of treatment - even for diseases that have yet to find therapeutic answers. Thanks to new knowledge of biotechnology, ever-increasing computing power and the advancement of artificial intelligence, we will be able to respond to patients' needs even faster.

Clinical pipeline

With our research and development pipeline, we target some of the highest-needing therapeutic areas.

Preclinical pipeline

Our preclinical pipeline is characterized by high levels of diversity

Dompé farmaceutici S.p.A. Single shareholder company / Share capital € 50.000.000,00
REA MI 289519 - A registered company in Milan, Italy / Tax code and VAT number IT00791570153